Views: 0 Author: Site Editor Publish Time: 2026-07-21 Origin: Site
Qualification and validation are closely related GMP activities, but they are not the same.
In pharmaceutical manufacturing, qualification is normally used to demonstrate that facilities, utilities, systems, and equipment are properly designed, installed, and operating as intended.
Validation provides documented evidence that a process, method, system, or procedure can consistently achieve its intended result.
A simple way to understand the difference is:
Qualification → Is the equipment or system fit for its intended use?
Validation → Can the process consistently deliver the required result?
Qualification and validation are connected throughout the pharmaceutical lifecycle. Understanding how they work together is essential when planning a new pharmaceutical factory, production line, cleanroom, water system, or manufacturing process.
Shanghai Marya provides pharmaceutical engineering, equipment, cleanroom, and qualification support for pharmaceutical manufacturing projects.
This guide explains the difference between qualification and validation, DQ/IQ/OQ/PQ, major validation types, documentation requirements, and practical pharmaceutical applications.
Table of Contents
The main difference is their focus.
Aspect | Qualification | Validation |
|---|---|---|
Primary Focus | Equipment, facilities, utilities and systems | Processes, methods, procedures and systems |
Main Question | Does it work as intended? | Does it consistently achieve the intended result? |
Typical Activities | DQ, IQ, OQ, PQ | Process, cleaning, analytical and computerized system validation |
Evidence | Qualification protocols and reports | Validation protocols and reports |
Timing | Normally precedes related process validation | Follows or overlaps with appropriate qualification activities |
Lifecycle | Initial qualification + maintenance of qualified state | Initial validation + continued validated state |
Examples | Filling machine, HVAC, water system | Filling process, cleaning process, analytical method |
The distinction should not be treated as an absolute separation.
Qualification and validation are parts of an integrated pharmaceutical quality system and should be planned using lifecycle and quality-risk-management principles.
Qualification is the documented process used to demonstrate that equipment, facilities, utilities, and systems are suitable for their intended use.
For example, before using a pharmaceutical filling machine for commercial manufacturing, the manufacturer may need documented evidence that:
The equipment design meets user requirements
The machine is installed correctly
Components and utilities match approved specifications
Controls and alarms operate correctly
The machine performs within defined operating ranges
The integrated equipment performs reproducibly
Qualification is commonly divided into:
DQ → IQ → OQ → PQ
These stages provide a structured approach for demonstrating equipment and system suitability.
WHO describes qualification as proving and documenting that premises, systems, and equipment are properly installed and/or work correctly and lead to expected results.
Validation focuses on demonstrating that a process, method, system, or procedure can consistently achieve its predetermined result.
For example, qualifying a filling machine demonstrates that the equipment performs correctly.
Validating the filling process demonstrates that the manufacturing process can consistently produce filled products meeting defined quality requirements.
Typical pharmaceutical validation activities include:
Process validation
Cleaning validation
Analytical method validation
Computerized system validation
The exact validation strategy depends on the product, process, equipment, regulatory requirements, and associated risks.
The FDA Process Validation Guidance describes process validation using a lifecycle approach focused on building scientific evidence that a manufacturing process can consistently deliver quality products.
The easiest way to understand the relationship is to consider the object being evaluated.
Examples:
Does the filling machine operate within its specified range?
Does the HVAC system maintain its intended operating conditions?
Does the purified-water system operate according to its design requirements?
Examples:
Can the filling process consistently achieve the required fill volume?
Can the cleaning procedure consistently reduce residues to established acceptance limits?
Can an analytical method consistently provide suitable results for its intended purpose?
Therefore:
Qualification establishes equipment/system capability.
Validation establishes process or method consistency.
They support each other rather than operate as completely independent GMP activities.
Equipment qualification commonly includes four stages.
DQ provides documented verification that the proposed design is suitable for its intended purpose.
Typical DQ activities may review:
User Requirement Specification (URS)
Equipment capacity
Process requirements
Materials of construction
Product-contact materials
Cleanability
Automation
Safety
Utility requirements
GMP requirements
Applicable standards
For a pharmaceutical filling line, DQ may confirm whether the proposed machine design can handle the required container sizes, fill volumes, production capacity, cleaning requirements, and automation strategy.
IQ confirms that the equipment or system has been installed according to approved design requirements, manufacturer recommendations, and relevant specifications.
Typical IQ checks include:
Equipment identification
Component installation
Materials
Piping
Wiring
Utilities
Instrumentation
Calibration status
Technical documentation
Manuals
Spare parts
Drawings
The purpose is to establish documented evidence that the installed equipment corresponds to the approved configuration.
OQ demonstrates that the installed equipment operates as intended throughout the defined operating ranges.
Testing may include:
Start/stop functions
Operating ranges
Speed controls
Temperature controls
Pressure controls
Alarms
Interlocks
Emergency stops
Sensors
HMI functions
Recipes
Critical operating parameters
Where appropriate, testing should include defined challenge or worst-case conditions.
PQ demonstrates that the equipment or system can perform effectively and reproducibly under defined operating conditions.
Depending on the equipment, PQ may evaluate:
Production performance
Process consistency
Capacity
Repeatability
Product-related operating conditions
PQ connects equipment capability more closely with routine operation.
The FDA's Q7A GMP Guidance defines DQ, IQ, OQ and PQ as established qualification activities and states that appropriate qualification of critical equipment and ancillary systems should be completed before process validation activities.
A simplified qualification lifecycle is:
URS
↓
Design Review
↓
DQ
↓
Equipment Manufacturing
↓
FAT
↓
Installation
↓
IQ
↓
OQ
↓
PQ
↓
Routine Operation
↓
Periodic Review / Change Control
↓
Requalification When Required
Not every project follows exactly the same sequence.
The scope and depth of qualification should be determined according to the equipment, intended use, project requirements, and quality risk assessment.
Validation covers several different areas of pharmaceutical manufacturing.
Process validation demonstrates that a manufacturing process can consistently produce output meeting predetermined quality requirements.
Examples include:
Tablet manufacturing
Sterile filling
Liquid preparation
Lyophilization
Capsule filling
Modern process validation should be viewed across the product lifecycle rather than as a one-time exercise.
FDA describes three broad lifecycle stages:
Process Design
↓
Process Qualification
↓
Continued Process Verification
This approach emphasizes maintaining process understanding and control during routine commercial manufacturing.
Cleaning validation provides documented evidence that a cleaning procedure can consistently achieve established cleanliness requirements.
It may consider:
Product residues
Cleaning-agent residues
Microbiological concerns where applicable
Equipment surfaces
Hard-to-clean locations
Worst-case products
Sampling methods
Acceptance criteria
Cleaning validation is particularly important for shared pharmaceutical manufacturing equipment.
Analytical method validation demonstrates that an analytical procedure is suitable for its intended purpose.
Depending on the method, characteristics may include:
Accuracy
Precision
Specificity
Linearity
Range
Detection or quantitation capability
Robustness
The applicable requirements depend on the analytical method and regulatory context.
Pharmaceutical operations increasingly depend on computerized systems for:
Equipment control
Electronic records
Batch information
Recipes
Monitoring
Laboratory data
Manufacturing execution
Validation activities should demonstrate that applicable computerized systems are fit for intended use and operate consistently according to defined requirements.
Consider a pharmaceutical liquid filling line.
The filling line first needs appropriate qualification.
DQ
Does the proposed design meet the URS for container size, filling range, capacity, materials, controls, and GMP requirements?
IQ
Was the filling line installed according to approved drawings and specifications?
OQ
Do filling controls, conveyors, sensors, alarms, interlocks, HMI functions, and operating ranges perform correctly?
PQ
Can the integrated equipment perform reproducibly under defined production conditions?
The focus then moves from the equipment itself to the manufacturing process.
Questions may include:
Does the filling process consistently achieve the required fill quantity?
Are critical process parameters controlled?
Does the process consistently meet predefined product requirements?
Can acceptable performance be maintained during routine manufacturing?
Therefore:
Qualified Filling Line ≠ Automatically Validated Filling Process
Qualification provides evidence that the equipment is capable of performing its intended functions.
Process validation provides evidence that the manufacturing process can consistently deliver the required result.
The same principle applies to pharmaceutical utilities.
For a pharmaceutical water system, qualification may verify:
System design
Installation
Pumps
Piping
Instruments
Flow
Temperature
Controls
Alarms
Sanitization functions
The broader lifecycle activities demonstrate that the system can consistently provide water meeting the defined quality requirements under routine operating conditions.
This is why equipment, utilities, processes, and validation strategy should be considered together during pharmaceutical-factory design.
Qualification and validation should not be considered one-time activities.
The qualified and validated state must be maintained throughout the lifecycle.
Requalification or revalidation may be considered after significant changes such as:
Equipment modification
Process change
Major maintenance
Software change
Utility modification
Facility change
Change in critical operating parameters
Product transfer
Repeated deviations
Adverse performance trends
Periodic review may also identify the need for additional qualification or validation work.
WHO guidance emphasizes ongoing review to ensure that the qualified or validated state is maintained throughout the lifecycle.
Documentation is fundamental to both activities.
Typical documents may include:
Document | Purpose |
|---|---|
Validation Master Plan | Defines overall validation strategy |
URS | Defines user requirements |
Risk Assessment | Identifies and evaluates risks |
DQ Protocol/Report | Documents design qualification |
IQ Protocol/Report | Documents installation qualification |
OQ Protocol/Report | Documents operational qualification |
PQ Protocol/Report | Documents performance qualification |
Validation Protocol | Defines validation tests and acceptance criteria |
Validation Report | Records results and conclusions |
SOPs | Define routine procedures |
Calibration Records | Demonstrate instrument status |
Training Records | Document personnel training |
Change Control | Controls modifications |
Deviation Records | Documents unexpected results |
WHO guidance identifies protocols, reports, SOPs, specifications, risk assessments, calibration records, sampling plans, testing plans, training records, and qualification/validation history among relevant documentation.
The documentation should demonstrate:
What Was Planned → What Was Tested → What Happened → Whether Acceptance Criteria Were Met → What Was Concluded
A Validation Master Plan (VMP) provides the overall framework for qualification and validation activities.
Depending on the facility and project, it can define:
Validation policy
Organizational responsibilities
Systems requiring qualification
Processes requiring validation
Documentation structure
Acceptance strategy
Change control
Requalification/revalidation approach
Schedule
Lifecycle management
The VMP should be appropriate to the size and complexity of the pharmaceutical operation.
WHO's GMP Guidelines on Validation provide detailed guidance covering qualification, validation planning, documentation, lifecycle management, and related GMP principles.
Not every component requires the same level of qualification or validation effort.
A risk-based approach helps determine:
What is critical?
What can affect product quality?
What needs testing?
How much testing is appropriate?
What are the worst-case conditions?
What needs continued monitoring?
For example, a component that directly controls a critical process parameter may require greater qualification attention than a component with no meaningful impact on product quality.
WHO recommends applying quality risk management when determining the need, scope, and extent of qualification and validation.
They are related but have different focuses.
Qualification → equipment/system suitability
Validation → consistent process/method/system results
A successful initial validation does not eliminate the need to maintain a validated state.
Changes, deviations, trends, and routine process data should be evaluated throughout the lifecycle.
Poorly defined URS documents can create problems throughout DQ, FAT, IQ, OQ, and PQ.
Define intended use before equipment design and procurement.
Qualification protocols should reflect the actual equipment and intended use.
Simply copying another project's protocol can leave critical functions untested.
Qualification should focus resources according to risk and GMP impact.
Unexpected results during qualification or validation should be documented, investigated, and resolved appropriately.
Changes to qualified equipment or validated processes should be evaluated for potential impact before implementation.
Factory Acceptance Testing can provide useful evidence before shipment, but FAT alone does not automatically replace site qualification activities.
The installed equipment must still be evaluated according to the approved qualification strategy.
These terms are also frequently confused.
FAT is normally performed at the equipment manufacturer's facility before shipment.
It may verify:
Equipment configuration
Basic operation
Controls
Alarms
Documentation
Agreed technical requirements
SAT is performed after the equipment arrives and is installed at the customer's site.
It helps confirm that equipment has been delivered, installed, and operates appropriately in the actual facility.
Qualification provides documented GMP evidence that the equipment or system is suitable for its intended use.
FAT and SAT results may support qualification activities where appropriately planned and documented, but they should not automatically be considered substitutes for the complete qualification strategy.
Qualification and validation form part of the pharmaceutical quality system.
WHO states that validation is an essential part of GMP and that qualification and validation should be applied throughout the lifecycle of products, processes, methods, systems, equipment, and utilities.
The WHO GMP Guidelines on Validation provide guidance on the relationship between qualification and validation, documentation, validation planning, risk management, and maintaining the validated state.
For process validation, the FDA Process Validation Guidance emphasizes a lifecycle approach based on process understanding, process qualification, and continued verification.
Regulatory requirements can vary by market, product type, and manufacturing operation. Pharmaceutical manufacturers should therefore determine which requirements apply to their specific project.
Shanghai Marya provides integrated pharmaceutical engineering and equipment solutions for pharmaceutical manufacturing projects.
The project scope can include:
Pharmaceutical production equipment
Filling lines
Cleanroom systems
Pharmaceutical water systems
HVAC systems
Engineering design
FAT
Installation and commissioning
SAT
Qualification-document support
For pharmaceutical equipment projects, qualification requirements should ideally be considered from the URS and design stage, rather than added only after installation.
This allows equipment design, documentation, instrumentation, controls, alarms, materials, and testing requirements to be aligned with the intended qualification strategy from the beginning.
For complete pharmaceutical projects, equipment qualification should also be coordinated with cleanroom, HVAC, utilities, process equipment, and facility requirements.
Qualification normally focuses on demonstrating that equipment, facilities, utilities, or systems are suitable for their intended use.
Validation focuses on demonstrating that a process, method, or system can consistently achieve its intended result.
They are common equipment qualification stages:
DQ — Design Qualification
IQ — Installation Qualification
OQ — Operational Qualification
PQ — Performance Qualification
Qualification normally precedes the related process validation activities, particularly for critical manufacturing equipment and ancillary systems.
However, qualification and validation should be managed as connected lifecycle activities rather than completely isolated steps.
PQ is generally considered part of equipment/system qualification.
It demonstrates that equipment and ancillary systems can perform effectively and reproducibly under defined conditions.
Process validation provides documented evidence that a manufacturing process can operate effectively and reproducibly to consistently produce output meeting predetermined specifications and quality attributes.
Cleaning validation demonstrates that a defined cleaning procedure can consistently achieve established cleanliness requirements.
Requalification repeats or reassesses appropriate qualification activities to confirm that equipment or systems remain in a qualified state.
It may be triggered by significant changes, maintenance, performance trends, or periodic review.
Revalidation is the repetition or reassessment of validation activities when necessary to demonstrate that a process or system remains in a validated state.
No.
FAT is normally conducted at the equipment manufacturer's facility before shipment.
IQ verifies the installed equipment or system against approved installation requirements.
FAT documentation may support qualification when appropriately planned, but the two activities are not identical.
For critical pharmaceutical manufacturing processes, appropriate equipment and ancillary systems should normally be qualified before related process validation activities.
The exact validation requirements depend on the product, process, regulatory requirements, and risk assessment.
Typical documents may include URS, risk assessments, DQ/IQ/OQ/PQ protocols and reports, calibration records, SOPs, drawings, certificates, deviation records, and change-control documentation.
The difference between qualification and validation in pharma can be summarized simply:
Qualification asks whether the equipment or system is suitable for its intended use.
Validation asks whether the process, method, or system can consistently achieve its intended result.
Qualification commonly follows:
DQ → IQ → OQ → PQ
Validation can include:
Process Validation → Cleaning Validation → Analytical Method Validation → Computerized System Validation
The two should not be treated as isolated compliance exercises. They are connected lifecycle activities used to establish and maintain control over pharmaceutical facilities, equipment, utilities, systems, and manufacturing processes.
For new pharmaceutical projects, qualification and validation requirements should be considered from the earliest stages of URS, facility design, and equipment selection.
Shanghai Marya provides pharmaceutical equipment, cleanroom, utility, engineering, installation, commissioning, FAT, SAT, and qualification-document support for pharmaceutical manufacturing projects.
